E. McLaurin

M. Abelson, F. Mah, G. Torkildsen, 2017, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study

J. Seaman, G. Weissgerber, E. McLaurin, 2022, Clinical ophthalmology.

A phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eye.

Kathryn S. Kennedy, G. Ousler, C. Semba, 2012, American journal of ophthalmology.

Bepotastine Besilate Ophthalmic Solution 1.5% for Up to 8 Hours Following Dosing Reduces Total Non-Ocular Symptoms, Rhinorrhea, and Tearing in a Multi-Site Clinical Model of Allergic Conjunctivitis

E. Meier, E. McLaurin, P. Gomes, 2009 .

Bepotastine Besilate Ophthalmic Solution 1.0% Provides Rapid Relief of Rhinorrhea, Total Non-Ocular Symptoms, Tearing, and Ciliary and Episcleral Hyperemia Following Dosing in a Multi-Site Clinical Model of Allergic Conjunctivitis

E. Meier, E. McLaurin, P. Gomes, 2009 .

Plasma Pharmacokinetic Parameters of Dexamethasone Following Administration of a Dexamethasone Intracanalicular Insert in Healthy Adults

S. Vantipalli, M. Goldstein, J. L. Metzinger, 2021, Clinical ophthalmology.

Low‐dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials

G. Torkildsen, E. McLaurin, J. Vittitow, 2018, Clinical & experimental optometry.

Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials

J. Ciolino, D. Hollander, Julia M. Williams, 2015, Clinical ophthalmology.

Alcaftadine 0.25% Versus Olopatadine 0.2% In Prevention Of Ocular Itching In Allergic Conjunctivitis

J. Ciolino, D. Hollander, Julia M. Williams, 2014 .

Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis

A. Adewale, A. Narvekar, G. Torkildsen, 2017, Clinical ophthalmology.

Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis.

S. Vantipalli, David G. Evans, M. Goldstein, 2021, American journal of ophthalmology-glaucoma.

A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study

T. Schlüter, J. Ciolino, G. Ousler, 2021, Cornea.

'A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1).

M. Senchyna, G. Ousler, D. Hollander, 2022, The ocular surface.

Preparation of some substituted imidazolidine-2,4-diones.

J. Sam, R. Shafik, E. McLaurin, 1969, Journal of pharmaceutical sciences.

Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials

J. Ciolino, Julia M. Williams, E. McLaurin, 2015, Clinical ophthalmology.

G. Novack, L. Katz, J. Serle, 2018, American journal of ophthalmology.

Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge Model.

M. Abelson, F. Mah, G. Torkildsen, 2017, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye Disease

C. Spana, G. Ousler, G. Torkildsen, 2023, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

A Randomized, Multicenter Phase 3 Clinical Trial Evaluating Intracanalicular Dexamethasone Insert for the Treatment of Allergic Conjunctivitis

E. McLaurin, Srilatha Vantipalli, Steven Silverstein, 2024, Clinical ophthalmology.

Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.

J. Garrigue, M. Amrane, D. Ismail, 2024, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.